PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

PAR. SP, page-53

  1. 1,626 Posts.
    lightbulb Created with Sketch. 173
    To add to that, to give PR his due, he has not
    succumbed to low ball offers from BP, but as
    the pressure builds to raise substantial finance,
    I am concerned he may cave in.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.